Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-30

Clinical Trial Update: Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of indacaterol salts in patients with asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indacaterol salts (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2011-08-30